Polymorphism  	Polymorphism  	 NNP	B-NP
of  	of  	 IN	I-NP
metalloproteinases  	metalloproteinases  	 JJ	I-NP
MMP-1  	MMP-1  	 NN	I-NP
and  	and  	 CC	O
MMP-2  	MMP-2  	 CD	B-NP
in  	in  	 IN	O
risk  	risk  	 NN	O
of  	of  	 IN	O
laryngeal  	laryngeal  	 JJ	B-NP
cancer  	cancer  	 NN	I-NP
The  	The  	 DT	O
laryngeal  	laryngeal  	 JJ	B-NP
cancer  	cancer  	 NN	I-NP
is  	is  	 VBZ	O
the  	the  	 DT	O
most  	most  	 RBS	O
common  	common  	 JJ	O
malignancy  	malignancy  	 NN	B-NP
of  	of  	 IN	O
the  	the  	 DT	O
head  	head  	 NN	O
and  	and  	 CC	O
neck  	neck  	 NN	B-NP
squamous  	squamous  	 NN	I-NP
cell  	cell  	 NN	I-NP
carcinoma 	carcinoma 	 NN	I-NP
.  	.  	 .	O
Recent  	Recent  	 JJ	B-NP
studies  	studies  	 NNS	I-NP
have  	have  	 VBP	O
revealed  	revealed  	 VBN	O
the  	the  	 DT	O
role  	role  	 NN	O
of  	of  	 IN	O
genetic  	genetic  	 JJ	B-NP
variations  	variations  	 NNS	I-NP
in  	in  	 IN	O
the  	the  	 DT	O
risk  	risk  	 NN	O
for  	for  	 IN	O
laryngeal  	laryngeal  	 JJ	B-NP
cancer 	cancer 	 NN	I-NP
.  	.  	 .	O
Polymorphic  	Polymorphic  	 JJ	B-NP
genes  	genes  	 NNS	I-NP
of  	of  	 IN	I-NP
matrix  	matrix  	 JJ	I-NP
metalloproteinases  	metalloproteinases  	 NN	I-NP
may  	may  	 MD	O
affect  	affect  	 VB	O
an  	an  	 DT	O
individual  	individual  	 JJ	B-NP
genetic  	genetic  	 JJ	I-NP
predisposition  	predisposition  	 NN	I-NP
to  	to  	 TO	O
the  	the  	 DT	O
occurrence  	occurrence  	 NN	O
and  	and  	 CC	O
clinical  	clinical  	 JJ	B-NP
implications  	implications  	 NNS	I-NP
of  	of  	 IN	O
the  	the  	 DT	O
disease 	disease 	 NN	O
.  	.  	 .	O
THE  	THE  	 DT	O
AIM  	AIM  	 NNP	O
OF  	OF  	 IN	O
THE  	THE  	 DT	O
PRESENT  	PRESENT  	 NNP	O
STUDY 	STUDY 	 NNP	O
:  	:  	 :	O
was  	was  	 VBD	O
to  	to  	 TO	O
evaluate  	evaluate  	 VB	O
the  	the  	 DT	O
role  	role  	 NN	O
of  	of  	 IN	O
polymorphic  	polymorphic  	 JJ	B-NP
variants  	variants  	 NN	I-NP
of  	of  	 IN	I-NP
MMP-1  	MMP-1  	 NNP	I-NP
and  	and  	 CC	O
MMP-2  	MMP-2  	 CD	B-NP
genes  	genes  	 NNS	I-NP
in  	in  	 IN	O
the  	the  	 DT	O
development  	development  	 NN	O
of  	of  	 IN	O
laryngeal  	laryngeal  	 JJ	B-NP
carcinoma 	carcinoma 	 NN	I-NP
.  	.  	 .	O
DNA  	DNA  	 NNP	B-NP
was  	was  	 VBD	O
extracted  	extracted  	 VBN	O
from  	from  	 IN	O
633  	633  	 CD	O
individuals  	individuals  	 NNS	O
including  	including  	 VBG	O
261  	261  	 CD	O
patients  	patients  	 NNS	O
with  	with  	 IN	O
laryngeal  	laryngeal  	 JJ	B-NP
carcinoma  	carcinoma  	 NN	I-NP
and  	and  	 CC	O
372  	372  	 CD	O
healthy  	healthy  	 JJ	O
volunteers 	volunteers 	 NNS	O
.  	.  	 .	O
Genotyping  	Genotyping  	 NNP	B-NP
was  	was  	 VBD	O
carried  	carried  	 VBN	O
out  	out  	 RP	O
using  	using  	 VBG	O
TaqMan 	TaqMan 	 JJ	B-NP
( 	( 	 -LRB-	I-NP
® 	® 	 NNP	I-NP
)  	)  	 -RRB-	I-NP
SNP  	SNP  	 NNP	I-NP
Genotyping  	Genotyping  	 NNP	I-NP
Assays  	Assays  	 NNP	I-NP
( 	( 	 -LRB-	O
Applied  	Applied  	 NNP	O
Biosystems 	Biosystems 	 NNP	O
,  	,  	 ,	O
USA 	USA 	 NNP	B-NP
) 	) 	 -RRB-	O
.  	.  	 .	O
The  	The  	 DT	O
distribution  	distribution  	 NN	B-NP
of  	of  	 IN	I-NP
polymorphisms  	polymorphisms  	 NN	I-NP
of  	of  	 IN	I-NP
metalloproteinases  	metalloproteinases  	 NN	I-NP
were  	were  	 VBD	O
analysed 	analysed 	 VBN	O
:  	:  	 :	O
-1607  	-1607  	 CD	O
1G 	1G 	 CD	O
/ 	/ 	 CD	O
2G  	2G  	 CD	O
MMP-1  	MMP-1  	 CD	O
and  	and  	 CC	O
-1306  	-1306  	 NNP	O
C 	C 	 NNP	B-NP
/ 	/ 	 NNP	I-NP
T  	T  	 NNP	I-NP
MMP-2  	MMP-2  	 NNP	I-NP
gene 	gene 	 NN	I-NP
.  	.  	 .	O
The  	The  	 DT	O
distribution  	distribution  	 NN	B-NP
of  	of  	 IN	I-NP
genotypes  	genotypes  	 NN	I-NP
of  	of  	 IN	O
-1607  	-1607  	 CD	O
1G 	1G 	 CD	O
/ 	/ 	 CD	O
2G  	2G  	 CD	O
MMP-1  	MMP-1  	 CD	O
polymorphism  	polymorphism  	 NNS	O
was  	was  	 VBD	O
significantly  	significantly  	 RB	O
different  	different  	 JJ	O
in  	in  	 IN	O
controls  	controls  	 NNS	O
vs  	vs  	 JJ	O
patients  	patients  	 NNS	O
( 	( 	 -LRB-	O
χ 	χ 	 FW	O
( 	( 	 -LRB-	O
2 	2 	 LS	O
)  	)  	 -RRB-	O
15.05 	15.05 	 NNP	O
,  	,  	 ,	O
p  	p  	 CD	O
< 	< 	 SYM	O
0.001 	0.001 	 CD	O
) 	) 	 -RRB-	O
.  	.  	 .	O
The  	The  	 DT	O
2G  	2G  	 CD	O
allele  	allele  	 CD	O
carriers  	carriers  	 NNS	O
of  	of  	 IN	O
MMP-1  	MMP-1  	 CD	B-NP
-1607  	-1607  	 CD	O
1G 	1G 	 CD	O
/ 	/ 	 CD	O
2G  	2G  	 CD	O
polymorphism  	polymorphism  	 NNS	O
were  	were  	 VBD	O
at  	at  	 IN	O
higher  	higher  	 JJR	O
risk  	risk  	 NN	O
for  	for  	 IN	O
laryngeal  	laryngeal  	 JJ	B-NP
carcinoma  	carcinoma  	 JJ	I-NP
development  	development  	 NN	I-NP
( 	( 	 -LRB-	O
p  	p  	 FW	O
< 	< 	 SYM	O
0.001 	0.001 	 FW	O
) 	) 	 -RRB-	O
.  	.  	 .	O
In  	In  	 IN	O
the  	the  	 DT	O
present  	present  	 JJ	O
study 	study 	 NN	O
,  	,  	 ,	O
2G 	2G 	 CD	O
/ 	/ 	 CD	O
2G  	2G  	 CD	O
polymorphic  	polymorphic  	 CD	O
variant  	variant  	 NNS	O
was  	was  	 VBD	O
the  	the  	 DT	O
independent  	independent  	 JJ	O
factor  	factor  	 NN	B-NP
of  	of  	 IN	I-NP
cancer  	cancer  	 NN	I-NP
development  	development  	 NN	I-NP
( 	( 	 -LRB-	O
p=0.0015 	p=0.0015 	 NNP	O
) 	) 	 -RRB-	O
.  	.  	 .	O
Presented  	Presented  	 VBN	O
data  	data  	 NNS	O
suggest  	suggest  	 VBP	O
an  	an  	 DT	O
implication  	implication  	 NN	O
of  	of  	 IN	O
MMP-1  	MMP-1  	 CD	B-NP
polymorphisms  	polymorphisms  	 NN	I-NP
in  	in  	 IN	O
the  	the  	 DT	O
laryngeal  	laryngeal  	 JJ	B-NP
carcinoma  	carcinoma  	 JJ	I-NP
susceptibility 	susceptibility 	 NN	I-NP
.  	.  	 .	O
The  	The  	 DT	O
presence  	presence  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
MMP-1  	MMP-1  	 CD	O
2G  	2G  	 CD	O
allele  	allele  	 NNS	O
seemed  	seemed  	 VBD	O
to  	to  	 TO	O
be  	be  	 VB	O
associated  	associated  	 VBN	O
with  	with  	 IN	O
increased  	increased  	 JJ	O
risk  	risk  	 NN	O
for  	for  	 IN	O
the  	the  	 DT	O
disease 	disease 	 NN	O
.  	.  	 .	O
In  	In  	 IN	O
summary 	summary 	 NN	O
,  	,  	 ,	O
the  	the  	 DT	O
current  	current  	 JJ	O
study  	study  	 NN	O
have  	have  	 VBP	O
provided  	provided  	 VBN	O
the  	the  	 DT	O
evidence  	evidence  	 NN	O
that  	that  	 IN	O
an  	an  	 DT	O
individual 	individual 	 NN	O
's  	's  	 POS	O
risk  	risk  	 NN	O
for  	for  	 IN	O
carcinoma  	carcinoma  	 NN	B-NP
of  	of  	 IN	I-NP
larynx  	larynx  	 NN	I-NP
is  	is  	 VBZ	O
modulated  	modulated  	 VBN	O
by  	by  	 IN	O
genetic  	genetic  	 JJ	B-NP
factors 	factors 	 NNS	I-NP
.  	.  	 .	O
